In vivo experiments have shown that APCMin mice lacking COX-2 develop 80% fewer intestinal neoplasias than mice that express wild type COX-2 [82], and these COX-2 deficient mice also develop 75% fewer papillomas than wild-type mice in a multistep tumor initiation/promotion model [83]. Here, PTGS2 is linked to papilloma.